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Introduction
Lung cancer remains a common cause of cancer deaths
worldwide. Most patients with lung cancer do not have
the option of surgical treatment when diagnosed because
of advanced disease. Even for patients receiving surgical
resection of lung cancer, the prognosis has not been
satisfactory, unless the disease was at an early stage.
Mountain1 revised the staging system in 1997 and
downstaged T3N0M0 to stage IIB as a result of favorable
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survival in patients with chest wall invasion, but without
nodal metastasis. Some series advocated that en bloc
resection of the chest wall and lung is the procedure of
choice to obtain complete resection in lung cancer
invading the chest wall.2–4 In contrast, Elia and associates5
demonstrated no statistical significance in 5-year survival
between the “extrapleural dissection” and the “en bloc”
resection groups. The authors concluded that surgical
treatment of stage IIB and IIIA non-small cell lung
cancer (NSCLC) invading the chest wall by extrapleural
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or “en bloc” resection is widely adopted and justified by
the good results, in terms of morbidity and relief of pain.
Survival always depends on the nodal status. The purpose
of this study was to retrospectively assess the results of
en bloc resection of chest wall and lung for NSCLC in a
15-year period and investigate the prognostic factors of
long-term survival.
Methods
From January 1986 to December 2000, of 1,820
patients having surgical treatment for NSCLC at Taipei
Veterans General Hospital, 42 (2.3%) patients with
neoplasms invading the chest wall underwent en bloc
chest wall and lung resection. The median age was 69.2
( 8.5 years (range, 39–81 years). The cut-margin of
chest wall was at least 2 cm away from the tumor in all
cases. Patients with incomplete resection and extrapleural
dissection for chest wall invasion were excluded from
the study. En bloc resection of the chest wall and the
lung was defined as removal of lung parenchyma in
continuity with parietal pleura and chest wall soft tissue
with bony structures. Extrapleural resection was defined
as extrapleural dissection of the tumor from the chest
wall with removal of lung parenchyma and a portion of
the overlying parietal pleura.4 If defects of the chest wall
were more than 5 cm in size after surgery, chest wall
reconstruction with mesh repair was carried out unless
the defect was located underneath the scapula. During
the study period, mediastinoscopy was not performed.
Epidural catheterization for pain control was performed
routinely. Adjuvant chemotherapy or irradiation was
given in cases of lymph node metastasis. Medical charts
were retrospectively reviewed, including patient
demographics, preoperative symptoms, operative
procedures, tumor cell type and size, removed nodal
status, pathologic stage, and survival. Follow-up data
were obtained by means of telephone contact and/or
office visit. Cancer was staged according to the revised
international staging system.1 The depth of chest wall
invasion was grouped into 2 categories on the basis of
the pathologic report: parietal pleura only and soft
tissue and/or bone invasion. The same attending
surgeon reviewed all pathologic reports. In-hospital
mortality was defined as death within 30 days of surgery
and death that occurred later but during the same
hospitalization. Continuous variables were summarized
as mean and standard deviation (SD), and categorical
variables as percentage of proportion. Mann-Whitney
U test was used to compare the age difference between
the in-hospital mortality group and the other patients.
Risk factors included in the survival analysis were:
smoking history, number of rib resections, number of
lymph node dissections, tumor size, depth of chest wall
invasion, node metastasis, and tumor cell type. Survival
curves of a risk factor at the different levels were
compared with log-rank test, and p values of less than
0.05 were considered significant.
Results
The demographic data are summarized in Table 1.
Thirty-three patients died (78.5%; in-house mortality)
in this study, and 9 patients were alive by the
closing date of the study. Mean follow-up time was 36
months. In-hospital mortality was 11.9% (5 of 42).
Table 1. General data of patients with lung cancer invading
the chest wall
No. patients 42
Sex, n (%)
Male 41 (97.6)
Female 1 (2.4)
Age, mean ( SD 69.2 ( 8.5
Mean follow-up time, mo (range) 36 (1–178)
No. smokers, n (%) 34 (81.0)
Pack-years, mean 30.2
Symptoms, n (%)
Chest pain 20 (47.6)
Cough 19 (45.2)
Hemoptysis 13 (31.0)
Tumor diameter, cm,
mean ( SD (range) 7.0 ( 2.7 (2.7–12)
Parietal pleural invasion, mean 5.15
Soft tissue/bone invasion, mean 7.62
No. lymph node dissections, n (%)
) 15 24 (57.1)
> 15 18 (42.9)
Operative procedures, n (%)
Lobectomy 35 (83.3)
Bilobectomy 1 (2.4)
Pneumonectomy 5 (11.9)
Wedge resection 1 (2.4)
Ribs resected, n (%)
1 rib 8 (19.0)
2 ribs 15 (35.7)
3 ribs 10 (23.8)
4 ribs 7 (16.7)
5 ribs 1 (2.4)
6 ribs 1 (2.4)
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Three patients died of pneumonia with respiratory
failure. The other 2 patients died of bronchopleural
fistula and upper gastrointestinal bleeding, respectively.
These 5 patients were significantly older than the
others in the study (79.0 ( 2.8 versus 67.9 ( 8.1 years,
2-sample t test, p = 0.005). The survival analysis is
summarized in Table 2. The overall 5-year survival
was 28.4%. Statistical significance of 5-year survival
between groups is only seen in the with or without
nodal metastasis comparison. The 5-year survival was
significantly longer in the patients with negative (N0)
nodal metastasis than those with N1 and/or N2 nodal
metastasis (Figure 1). The 5-year survival rate was not
significantly different between the patients with
involvement of the parietal pleura only, and those
with involvement of the parietal pleura and the soft
tissue and/or bone (10.9% with 23 months median
Figure 1. The survival curve of the patients with or without nodal
metastasis (p = 0.01).
Table 2. Comparison of long-term survival of patients between groups (n = 42)
n (%) Median survival, mo 5-year survival, % p value
Patients 42 28.4
Smoking
< 30 PPD = years 19 (45.2) 7 21.0 0.32
* 30 PPD = years 23 (54.8) 14 35.5
Ribs resected
) 2 23 (54.8) 7 20.2 0.35
> 2 19 (45.2) 23 39.1
Tumor size, cm
) 6 21 (50%) 14 39.1 0.36
> 6 21 (50%) 7 25.2
No. of lymph node dissections
) 15 24 (57.1) 7 25.0 0.42
> 15 18 (42.9) 14 32.3
Nodal metastasis
N0 28 (67.6) 26 39.6 0.01*
N1 and/or N2 14 (32.4) 7 7.1
Chest wall invasion
Parietal pleural 11 (26.2) 23 10.9 0.94
Soft tissue and/or bone 31 (73.8) 8 33.5
Tumor cell type
Squamous cell carcinoma 24 (57.1) 9 33.3 0.76
Adenocarcinoma 9 (21.4) 14 16.7
Adenosquamous 3 (7.1) – –
Others 6 (14.2) – –
Adjuvant radiotherapy
With 15 (35.7) 7 20 0.156
Without 27 (64.3) 12 31.8
PPD = years = packs per day = years of smoking.
*The 5-year survival was significantly different between the N0 and N1/2 patients by log-rank test (p < 0.05).
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versus 33.5% with 8 months median, p = 0.94). There
was no significant difference in 5-year survival rates
between patients with squamous cell carcinoma and
patients with adenocarcinoma (33.3% with 9 months
median versus 16.7% with 14 months median, p =
0.76). Adjuvant radiotherapy also had no impact on
survival (p = 0.156).
Discussion
Controversy exists as to whether full-thickness chest
wall resection is necessary in all patients, especially
those with invasion only to the parietal pleura. Although
some authors6,7 reported their experiences of
extrapleural dissection and en bloc resection for chest
wall invasion, and found that survival was not
significantly affected by the operative procedure, it is
always debatable if the completeness of resection can
be achieved by extrapleural dissection and confirmation
by intraoperative biopsy on the deeper and nearby
tissue. Trastek et al8 reported an improved survival
with a chest wall resection as compared with extrapleural
resection. In the series of Albertucci et al,3 the rate of
local recurrence was significantly lower in patients
undergoing en bloc chest wall resection than in
patients undergoing extrapleural resection. The 5-year
survival rate was better in patients after en bloc resection
of the chest wall than in those with extrapleural
resection in the absence of lymph node metastasis.
Actually, it is sometimes not easy to identify the extent
of tumor invasion into the chest wall from the
preoperative image study unless there is apparent rib
destruction or intercostal muscle involvement.9 It is
also not easy to decide if the tumor invasion is only
limited to the parietal pleura at exploration. From
previous reports,6,7,10,11 we observed that the patients
receiving full-thickness resection of the chest wall were
more likely to have soft tissue and/or bone invasion
than to have parietal pleura invasion only. We had the
same finding in our series. This may explain the higher
percentage of incomplete resections and local recurrence
in the patients who underwent extrapleural dissection
if the tumor adhered closely to the chest wall.
Our study showed significantly higher 5-year
survival in the patients with negative (N0) nodal
metastasis than in those with N1 and/or N2 nodal
metastasis (39.6% versus 7.1%, p = 0.01). In 1997, the
International Staging System for Lung Cancer1 revised
T3N0M0 from stage IIIA to stage IIB in consideration
of favorable survival reported following extended
resection of the chest wall in cases without lymph node
involvement. The 5-year survival can go up to 61.4%
in N0 cases, according to the report by Facciolo et al,4
a series enrolling 104 patients having en bloc chest
wall and lung resection for lung cancer invading the
chest wall. Because of poor 5-year survival in the
patients with positive local lymph node metastasis,
some authors recommended conducting a clinical trial
with or without induction chemotherapy before
proceeding to surgery for these T3N1–2 patients. The
mediastinoscopy, a useful tool for preoperative staging
for lung cancer, should be performed as the preoperative
assessment for patients with suspected lymph node
metastasis and chest wall involvement.6,10
Our study consisted of a unique group of patients,
including 41 men and only 1 woman of relatively old
age. The 5 patients who died of postoperative
complications had a mean age of 79.0 years (range,
74–81 years), which was significantly older than the
patients who survived the operation. Many surgeons
have been concerned about the high mortality
associated with chest wall and lung resection.2 Martin-
Ucar et al12 also reported that, in cases of lung cancer
with chest wall invasion, en bloc pulmonary and chest
wall resection was associated with a significantly
increased 60-day mortality. The number of rib
resections in our 5 patients was 1 resection in 2
patients, 2 resections in 1 patient, and 4 resections in
2 patients. The mean segmental rib resection was 2.6.
The procedures that these patients received included
3 lobectomies, 1 wedge resection, and 1 pneumonectomy.
The extent of resection and the operative procedure
of these patients did not differ from other patients.
A more careful preoperative evaluation, such as
mediastinoscopy or positron emission tomography
scan, is recommended in elderly people if extensive
chest wall plus lung resection is to be done.
For patients of lung cancer with chest wall invasion,
long-term survival is influenced by completeness of
the resection and the nodal status. In our series, the
patients with soft tissue or bone invasion had better
5-year survival than patients with parietal pleura invasion
only, although the difference was not statistically
significant. Chapelier et al10 reported the depth of
chest wall invasion as an independent factor affecting
long-term survival. In contrast, McCaughan et al13 did
not find the depth of chest wall invasion influenced
survival unless there was lymphatic metastases. Pitz et
al6 also reported no relationship between survival and
the depth of chest wall invasion. Our scrutiny found
that 5 (45.4%) of 11 patients with parietal pleura
invasion had N1 or N2 nodal metastasis, while only 9
(29.0%) of 31 patients with soft tissue or bone invasion
had N1 or N2 nodal invasion. Among the patients
without nodal involvement, better survival was
Lung cancer with chest wall invasion
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evidenced in those with soft tissue or bone invasion
than in those with parietal pleura invasion only (median
survival: 33 versus 14 months; 5-year survival rate: 41.7%
versus 50.0%), although the difference did not reach
statistical significance (p = 0.816). The reason why
patients with parietal pleura invasion were more likely
to have lymphatic metastasis was not determined in
our series. Other various factors, including tobacco
use, number of lymph node dissections, tumor cell
type, tumor size, and the extent of chest wall resection,
seemed not to affect the survival in our series. In the
series of Riquet et al,14 the use of adjuvant therapy
seemed to have little influence on survival of patients
having lung cancer with chest wall invasion. Burhart et
al11 observed the best survival in women with T3N0M0
disease. Piehler et al,15 in their early report, stated that,
among patients with T3N0M0 neoplasms, 5-year
survival was 84.6% for those younger than 60 years of
age and 27.7% for those older than 60.
In conclusion, en bloc resection for bronchogenic
carcinoma invading the chest wall provides a favorable
prognosis in cases without nodal metastasis. The depth
of chest wall invasion does not affect the 5-year
survival. Significant postoperative mortality is associated
with age older than 80 years. Careful preoperative
evaluation is advocated to prevent serious complications
in this patient group.
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